- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8 result(s) found for: Gyrus.
Displaying page 1 of 1.
EudraCT Number: 2018-001257-27 | Sponsor Protocol Number: S61444 | Start Date*: 2018-05-22 |
Sponsor Name:KU Leuven | ||
Full Title: Cognitive brain circuits and the spread of tau in vivo in humans | ||
Medical condition: Alzheimer disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001079-39 | Sponsor Protocol Number: 019/06 | Start Date*: 2006-07-27 |
Sponsor Name:Universitätsklinikum Bonn; Klinik und Poliklinik für Psychiatrie und Psychotherapie | ||
Full Title: Interozeptive Aufmerksamkeit, Hitze-Schwelle und körperliche Symptome bei Patienten mit einer depressiven Episode, vor und nach Behandlung mit Duloxetin. Eine Pilotstudie mittels funktioneller Mag... | ||
Medical condition: Diagnose einer „Major Depression“ (DSM-IV: 296.xx). Der Gesamtscore der Hamilton-Depressionsskala-17 muß mindestens 15 betragen. Zudem müssen die Patienten unter Schmerzsymptomen leiden. Dieses Kri... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000454-22 | Sponsor Protocol Number: NL43068.058.13 | Start Date*: 2013-08-21 | |||||||||||
Sponsor Name: | |||||||||||||
Full Title: (Grand)parenting, oxytocin, and the oxytocin receptor gene: an fMRI and observational study | |||||||||||||
Medical condition: There are no medical conditions or diseases under investigation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003750-89 | Sponsor Protocol Number: KKS-186 | Start Date*: 2013-02-14 | |||||||||||
Sponsor Name:Philipps-University Marburg | |||||||||||||
Full Title: A placebo-controlled, double blind, randomised trial with crossover-design investigating the effect of oxytocin nasal spray on neuronal processes of empathy | |||||||||||||
Medical condition: high-functioning autism spectrum disorders: autistic disorder (F84.0), Asperger syndrome (F84.5), atypical autism (F 84.1) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004455-36 | Sponsor Protocol Number: ATO-TS | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:CHU DE POITIERS | |||||||||||||
Full Title: Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients. | |||||||||||||
Medical condition: High impulsive Tourette’s syndrome patients | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018416-33 | Sponsor Protocol Number: 2009_37/1001 | Start Date*: 2010-07-13 | |||||||||||
Sponsor Name:Centre Hospitalier Régional et Universitaire de Lille | |||||||||||||
Full Title: Effets du Fénofibrate durant la première année de schizophrénie (effects of Fenofibrate® in first year of schizophrenia) | |||||||||||||
Medical condition: schizophrénia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000307-17 | Sponsor Protocol Number: DIAN-TU-001 | Start Date*: 2014-01-08 |
Sponsor Name:Washington University in St. Louis | ||
Full Title: A Phase II/III randomized, double-blind, placebo-controlled, cognitive endpoint, multicenter study of potential disease modifying therapies in individuals at risk for and with dominantly inherited ... | ||
Medical condition: Dominantly Inherited Alzheimer Disease (DIAD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) IT (Ongoing) ES (Temporarily Halted) DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004740-30 | Sponsor Protocol Number: PHRCN2018 | Start Date*: 2021-09-15 | |||||||||||
Sponsor Name:Centre Hospitalier Le Vinatier | |||||||||||||
Full Title: Cannabidiol for reducing drinking in alcohol use disorder and modifying the effects of alcohol on the brain and the liver: a phase 2 clinical trial. | |||||||||||||
Medical condition: CARAMEL is an exploratory phase-2 study conducted in subjects with AUD (alcohol use disorder) and current heavy drinking level, aiming to confirm the different properties of CBD observed in animal ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.